Protocol for automated production of human stem cell derived liver spheres
Summary: This protocol describes how to produce human liver spheres from pluripotent stem cell-derived hepatic progenitors, endothelial cells, and hepatic stellate cells. Liver spheres form by self-assembly in microwells, generating up to 73 spheres per well of a 96-well plate. This process was auto...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | STAR Protocols |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166721002094 |
id |
doaj-c545e9cb181540ee87b21a9245f16b38 |
---|---|
record_format |
Article |
spelling |
doaj-c545e9cb181540ee87b21a9245f16b382021-06-21T04:25:26ZengElsevierSTAR Protocols2666-16672021-06-0122100502Protocol for automated production of human stem cell derived liver spheresJose Meseguer-Ripolles0Alvile Kasarinaite1Baltasar Lucendo-Villarin2David C. Hay3Centre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UK; Corresponding authorCentre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UKCentre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UKCentre for Regenerative Medicine, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh BioQuarter, 5 Little France Drive, Edinburgh EH16 4UU, UK; Corresponding authorSummary: This protocol describes how to produce human liver spheres from pluripotent stem cell-derived hepatic progenitors, endothelial cells, and hepatic stellate cells. Liver spheres form by self-assembly in microwells, generating up to 73 spheres per well of a 96-well plate. This process was automated using liquid handling and pipetting systems, permitting cost-effective scale-up and reducing sphere variability. In its current form, this system provides a powerful tool to generate human liver tissue for disease modeling and drug screening.For complete details on the use and execution of this protocol, please refer to Lucendo-Villarin et al. (2020) (https://doi.org/10.1088/1758-5090/abbdb2).http://www.sciencedirect.com/science/article/pii/S2666166721002094MetabolismStem CellsCell DifferentiationTissue Engineering |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jose Meseguer-Ripolles Alvile Kasarinaite Baltasar Lucendo-Villarin David C. Hay |
spellingShingle |
Jose Meseguer-Ripolles Alvile Kasarinaite Baltasar Lucendo-Villarin David C. Hay Protocol for automated production of human stem cell derived liver spheres STAR Protocols Metabolism Stem Cells Cell Differentiation Tissue Engineering |
author_facet |
Jose Meseguer-Ripolles Alvile Kasarinaite Baltasar Lucendo-Villarin David C. Hay |
author_sort |
Jose Meseguer-Ripolles |
title |
Protocol for automated production of human stem cell derived liver spheres |
title_short |
Protocol for automated production of human stem cell derived liver spheres |
title_full |
Protocol for automated production of human stem cell derived liver spheres |
title_fullStr |
Protocol for automated production of human stem cell derived liver spheres |
title_full_unstemmed |
Protocol for automated production of human stem cell derived liver spheres |
title_sort |
protocol for automated production of human stem cell derived liver spheres |
publisher |
Elsevier |
series |
STAR Protocols |
issn |
2666-1667 |
publishDate |
2021-06-01 |
description |
Summary: This protocol describes how to produce human liver spheres from pluripotent stem cell-derived hepatic progenitors, endothelial cells, and hepatic stellate cells. Liver spheres form by self-assembly in microwells, generating up to 73 spheres per well of a 96-well plate. This process was automated using liquid handling and pipetting systems, permitting cost-effective scale-up and reducing sphere variability. In its current form, this system provides a powerful tool to generate human liver tissue for disease modeling and drug screening.For complete details on the use and execution of this protocol, please refer to Lucendo-Villarin et al. (2020) (https://doi.org/10.1088/1758-5090/abbdb2). |
topic |
Metabolism Stem Cells Cell Differentiation Tissue Engineering |
url |
http://www.sciencedirect.com/science/article/pii/S2666166721002094 |
work_keys_str_mv |
AT josemeseguerripolles protocolforautomatedproductionofhumanstemcellderivedliverspheres AT alvilekasarinaite protocolforautomatedproductionofhumanstemcellderivedliverspheres AT baltasarlucendovillarin protocolforautomatedproductionofhumanstemcellderivedliverspheres AT davidchay protocolforautomatedproductionofhumanstemcellderivedliverspheres |
_version_ |
1721369037625098240 |